PUBLISHER: Grand View Research | PRODUCT CODE: 2040645
PUBLISHER: Grand View Research | PRODUCT CODE: 2040645
The global drug-coated balloon catheter market size was estimated at USD 1.2 billion in 2025 and is projected to reach USD 2.3 billion by 2033, growing at a CAGR of 8.3% from 2026 to 2033. The rising prevalence of cardiovascular diseases and increasing incidence of coronary and peripheral artery disease continue to boost the need for practical, minimally invasive vascular interventions, which are key drivers of market growth.
According to Oxford Academic in January 2025, the global age-standardized prevalence of CVD is estimated at approximately 7,179 cases per 100,000 population, highlighting the persistent global burden of heart-related disorders. This high prevalence is driving demand for drug coated balloon catheters, which offer an effective, minimally invasive option for treating vascular narrowing and reducing restenosis in patients with coronary and peripheral artery disease, thereby supporting their growing adoption in interventional cardiology.
The market is witnessing strong growth driven by the rising prevalence of vascular diseases such as peripheral artery disease (PAD), increasing clinical adoption supported by superior outcomes over conventional balloons, and expanding use across hospitals and specialized cardiac centers. These devices offer effective revascularization without leaving permanent implants, making them a preferred minimally invasive treatment option. Advancements in imaging and the integration of AI-enabled procedural guidance are enhancing treatment precision and physician confidence, further accelerating the adoption of DCB technologies across interventional cardiology practices.
Increasing prevalence of Peripheral Artery Disease (PAD)
The increasing prevalence of Peripheral Artery Disease (PAD) remains a key driver of the drug-coated balloon (DCB) catheter industry. According to the American Limb Preservation Society. article published in July 2025, the projected 220% increase in peripheral artery disease (PAD) cases worldwide by 2050, with prevalence expected to rise from 113 million in 2021 to over 360 million, highlights a rapidly expanding patient population requiring vascular intervention. This rise is fuels demand for drug-coated balloon catheters, which are widely used in PAD treatment to restore vessel patency and reduce restenosis without leaving permanent implants, making them a preferred option for managing the growing PAD burden.
Global Drug-coated Balloon Catheter Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug-coated balloon catheter market report based on type, end use, and region: